Introduction:
In recent years, the veterinary vaccine market in China has experienced significant growth, driven by increasing pet ownership and the rising demand for livestock production. According to industry reports, the veterinary vaccine market in China is expected to reach a market size of $1.5 billion by 2026. In this report, we will shine a spotlight on the top 50 veterinary vaccine producers in China in 2026.
Top 50 Veterinary Vaccine Producers in China 2026:
1. Jinyu Bio-technology Co., Ltd.
Jinyu Bio-technology Co., Ltd. is a leading veterinary vaccine producer in China, with a production volume of over 100 million doses annually. The company holds a significant market share in the domestic market and has been expanding its export business to international markets.
2. China Animal Husbandry Group
China Animal Husbandry Group is one of the largest veterinary vaccine producers in China, with a diversified product portfolio covering vaccines for various livestock and companion animals. The company’s exports have been steadily increasing, with a trade value of $50 million in 2026.
3. Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a key player in the veterinary vaccine market in China, known for its high-quality products and innovative research initiatives. The company’s production volume has been growing at a steady pace, reaching 80 million doses in 2026.
4. Guangdong Dahuanong Animal Health Products Co., Ltd.
Guangdong Dahuanong Animal Health Products Co., Ltd. is a prominent veterinary vaccine producer in China, specializing in vaccines for poultry and swine. The company has a strong presence in the domestic market and has been expanding its global footprint, with exports to Southeast Asian countries.
5. Tianjin Ringpu Bio-Technology Co., Ltd.
Tianjin Ringpu Bio-Technology Co., Ltd. is a fast-growing veterinary vaccine producer in China, known for its cutting-edge research and development capabilities. The company’s market share has been increasing steadily, with a focus on vaccines for companion animals.
Insights:
The veterinary vaccine market in China is poised for continued growth in the coming years, driven by factors such as increasing pet ownership, rising awareness of animal health, and government initiatives to improve livestock production. With the implementation of stricter regulations and quality standards, we can expect to see consolidation within the industry, with larger players dominating the market. By 2026, the veterinary vaccine market in China is projected to reach new heights, with a market size of $2 billion and a significant increase in exports to international markets.
Related Analysis: View Previous Industry Report
